透過您的圖書館登入
IP:3.148.106.2

摘要


何氏細胞腫瘤(Hürthle cell tumor)為一罕見且具潛在致命性的濾泡性甲狀腺腫瘤變異型。細針抽吸細胞學檢查並無法分辨何氏細胞腺瘤(Hürthle cell adenoma)與何氏細胞癌(Hürthle cell carcinoma),絕大多數的外科醫師建議對於何氏細胞腺瘤,僅須接受甲狀腺全葉切除術(total lobectomy),而何氏細胞癌才須接受全甲狀腺切除手術(total thyroidectomy)治療。本例為49歲女性之何氏細胞腺瘤患者,經左側甲狀腺全葉切除術後意外發現為何氏細胞腺瘤,於門診定期追蹤l年,無復發跡象,因屬臨床上少見之病例,特就其臨床表現及治療提出報告。

並列摘要


Hürthle cell tumors are rare and potentially lethal variant of follicular tumors of the thyroid. Fine needle aspiration cytology is not possible to differentiate Hürthle cell adenoma from Hürthle cell carcinoma. The majority of surgeons recommend thyroid total lobectomy for Hürthle cell adenoma and total thyroidectomy for Hürthle cell carcinoma. We describe a 49-year-old woman who was a victim of Hürthle cell adenoma. She was admitted and received thyroid total lobectomy. After surgery, she was arranged to have regular follow up. There was no recurrence for more than one year.

延伸閱讀


國際替代計量